Community Health Systems, Inc. reported its financial and operating results for the second quarter ended June 30, 2026, reflecting a challenging operating environment marked by lower revenues driven by divestitures, an unfavorable payor mix shift, and higher medical specialist fees, partially offset by volume gains and improved reimbursement rates on a same-store basis.

Second Quarter Financial Highlights

For the three months ended June 30, 2026, net operating revenues totaled $2.825 billion, a 9.8 percent decrease compared to $3.133 billion for the same period in 2025. On a same-store basis, however, net operating revenues increased 2.4 percent. The following table summarizes key financial metrics for the quarter:

On a same-store basis, admissions increased 1.9 percent and adjusted admissions increased 2.9 percent compared to the same period in 2025. The decrease in Adjusted EBITDA was primarily attributable to divestitures, an unfavorable change in payor mix, and higher medical specialist fees, partially offset by increased volumes and reimbursement rates, a higher net benefit from supplemental reimbursement programs, and lower contract labor and professional liability expenses.

Six-Month Performance

For the six months ended June 30, 2026, net operating revenues totaled $5.790 billion, an 8.0 percent decrease compared to $6.292 billion for the same period in 2025. On a same-store basis, net operating revenues increased 2.5 percent. The table below presents the key metrics for the first half of the year:

The decrease in net income for the six-month period was primarily due to a period-over-period change in loss (gain) from early extinguishment of debt, an increase in the provision for income taxes, and factors contributing to the decrease in Adjusted EBITDA, partially offset by lower interest expense.

Debt Management and Divestitures

During the period, the company used approximately $600 million of cash on hand from recent divestiture proceeds to repurchase approximately $368 million principal amount of its 4.750% Senior Secured Notes due 2031 (approximately 35 percent of total outstanding principal) and approximately $231 million principal amount of its 10.875% Senior Secured Notes due 2032 (approximately 13 percent of total outstanding principal) via a tender offer completed on May 6, 2026. A pre-tax loss from early extinguishment of debt of approximately $5 million was recognized during the three months ended June 30, 2026.

During 2026 through the date of the press release, the company divested its 80 percent ownership interest in one hospital (completed February 1, 2026) and eight other hospitals across multiple completion dates.

Updated Full-Year 2026 Guidance

Management updated its full-year 2026 guidance alongside the quarterly results. The revised outlook is presented below alongside the prior guidance range:

CEO Kevin J. Hammons commented: "Our dedicated team is making measurable progress across top priorities that include clinical quality, patient and physician experience and employee satisfaction, while also investing in initiatives designed to fuel future growth. We are confident in our ability to deliver long-term value by managing the factors within our control and successfully navigating the dynamic macroeconomic environment."

As of July 22, 2026, the company's subsidiaries own or lease 60 affiliated hospitals with more than 8,000 beds and operate more than 800 sites of care across 32 distinct markets in 12 states, headquartered in Franklin, Tennessee.

Truist Securities analyst David Macdonald has maintained a Hold rating on Community Health Systems (NYSE: CYH) while raising the price target to $3.75. The adjustment follows a previous downgrade by Barclays to Underweight with a price target of $3. The revised target suggests a potential upside based on the firm's valuation analysis over the next 12 months.

Rating and Target Details

The Hold rating indicates a neutral stance on the stock's performance relative to the market. The increase in the price target reflects updated financial projections or market conditions.

The contrasting views from analysts highlight differing perspectives on the company's near-term trajectory. Investors should consider the rationale behind the target adjustments when evaluating the stock.